Xanthelasma
Xanthelasma | |
---|---|
Other names | xanthelasma palpebrarum; xanthoma palpebrarum |
![]() | |
Pronunciation | |
Specialty | Ophthalmology ![]() |
Xanthelasma is a sharply demarcated yellowish deposit of
A xanthelasma may be referred to as a xanthoma when becoming larger and nodular, assuming tumorous proportions.[5] Xanthelasma is often classified simply as a subtype of xanthoma.[6]
Diagnosis
Xanthelasma in the form of XP can be diagnosed from clinical impression, although in some cases it may need to be distinguished (
Treatment
Xanthelasmata can be removed with a trichloroacetic acid peel, surgery, lasers or cryotherapy.[2] Removal may cause, although uncommon, scarring and pigment changes.
Prognosis
Recurrence is common: 40% of patients with XP had recurrence after primary surgical excision, 60% after secondary excision, and 80% when all four eyelids were involved. A possible cause might be insufficiently deep excisions.[2]
Epidemiology
Xanthelasma is a rare disorder in the general population, with a variable incidence of 0.56 to 1.5% in western developed countries. The age of onset ranges from 15 to 75, with a peak in the 4th to 5th decades of life. There also seems to be a greater prevalence in females, but this might be due to higher consciousness to cosmetic defects.[7]
Etymology
The word is derived from Greek xanthós, ξανθός 'yellow' and élasma, έλασμα, 'foil'. The plural is xanthelasmata.
See also
- Xanthoma, a similar collection of cholesterol around tendons
- List of xanthoma variants associated with hyperlipoproteinemia subtypes
References
- ^ a b c
Frew JW, Murrell DF, Haber RM (October 2015). "Fifty shades of yellow: a review of the xanthodermatoses". International Journal of Dermatology. 54 (10): 1109–1123. PMID 26227781.
- ^ PMID 29296091.
- ^
Ozdöl S, Sahin S, Tokgözoğlu L (August 2008). "Xanthelasma palpebrarum and its relation to atherosclerotic risk factors and lipoprotein (a)". International Journal of Dermatology. 47 (8): 785–9. S2CID 25746456.
- ^
Chang, Hua-Ching; Sung, Chih-Wei; Lin, Ming-Hsiu (March 2020). "Serum lipids and risk of atherosclerosis in xanthelasma palpebrarum: A systematic review and meta-analysis". Journal of the American Academy of Dermatology. 82 (3): 596–605. S2CID 202413378.
- ^
Shields C, Shields J (2008). Eyelid, conjunctival and orbital tumors: atlas and textbook. Hagerstwon, MD: Lippincott Williams & Wilkins. ISBN 978-0-7817-7578-6.[page needed]
- ^
Xanthelasma (8th ed.). 2009. Retrieved November 8, 2012.
{{cite book}}
:|work=
ignored (help) - PMID 23105704.